NM_015321.3:c.929G>C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_015321.3(CRTC1):​c.929G>C​(p.Gly310Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,460,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000062 ( 0 hom. )

Consequence

CRTC1
NM_015321.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.19

Publications

0 publications found
Variant links:
Genes affected
CRTC1 (HGNC:16062): (CREB regulated transcription coactivator 1) Enables cAMP response element binding protein binding activity. Involved in positive regulation of transcription by RNA polymerase II. Located in cytosol; nuclear body; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.036869228).
BS2
High AC in GnomAdExome4 at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRTC1NM_015321.3 linkc.929G>C p.Gly310Ala missense_variant Exon 9 of 14 ENST00000321949.13 NP_056136.2 Q6UUV9-1
CRTC1NM_001098482.2 linkc.977G>C p.Gly326Ala missense_variant Exon 10 of 15 NP_001091952.1 Q6UUV9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRTC1ENST00000321949.13 linkc.929G>C p.Gly310Ala missense_variant Exon 9 of 14 1 NM_015321.3 ENSP00000323332.7 Q6UUV9-1
CRTC1ENST00000338797.10 linkc.977G>C p.Gly326Ala missense_variant Exon 10 of 15 1 ENSP00000345001.5 Q6UUV9-2
CRTC1ENST00000594658.5 linkc.806G>C p.Gly269Ala missense_variant Exon 9 of 14 1 ENSP00000468893.1 M0QX46
CRTC1ENST00000601916.1 linkc.704G>C p.Gly235Ala missense_variant Exon 8 of 10 5 ENSP00000469285.1 M0QXN6

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000200
AC:
5
AN:
250418
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000616
AC:
9
AN:
1460674
Hom.:
0
Cov.:
31
AF XY:
0.00000550
AC XY:
4
AN XY:
726682
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86162
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52558
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111824
Other (OTH)
AF:
0.00
AC:
0
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.000111
Hom.:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 15, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.977G>C (p.G326A) alteration is located in exon 10 (coding exon 10) of the CRTC1 gene. This alteration results from a G to C substitution at nucleotide position 977, causing the glycine (G) at amino acid position 326 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
12
DANN
Benign
0.71
DEOGEN2
Benign
0.17
T;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.068
N
LIST_S2
Benign
0.83
T;T;T;T
M_CAP
Benign
0.0040
T
MetaRNN
Benign
0.037
T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.2
M;.;.;.
PhyloP100
1.2
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.21
N;N;.;.
REVEL
Benign
0.063
Sift
Benign
0.72
T;T;.;.
Sift4G
Benign
0.61
T;T;T;T
Polyphen
0.0
B;B;.;.
Vest4
0.13
MutPred
0.086
Loss of catalytic residue at A309 (P = 0.1011);.;.;.;
MVP
0.36
MPC
0.62
ClinPred
0.88
D
GERP RS
0.077
Varity_R
0.034
gMVP
0.20
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770215721; hg19: chr19-18876256; API